Evidence map›Paper›PMID 42875459›Full record

Observational studyNature communications2026

Multimodal data-driven clustering analysis of heart failure patients identifies two distinct patterns of heart failure with preserved ejection fraction: Results from the PACIFIC-PRESERVED study.

Jean-Sébastien Hulot, Pierre-Yves Hervé, Nicolas Girerd, Frédérique Chézalviel-Guilbert, Philip Janiak, Pierre Boutouyrie, Jean-Joseph Christophe, Ariel Cohen, Thibaud Damy, Liliane Berkani and 15 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04189029 (Redefining the Phenotypic Spectrum of Heart Failure With Preserved Ejection Fraction), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04189029 unknown statusnot on this map

Redefining the Phenotypic Spectrum of Heart Failure With Preserved Ejection Fraction (HFpEF) by Deep Phenotyping and Machine Learning Methods: The PACIFIC-PRESERVED Study (PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study)

Typeobservational_patient_registrySponsorAssistance Publique - Hôpitaux de ParisRan2019 to 2025Enrolled175ConditionsHeart Failure, Heart Failure With Preserved Ejection FractionArmsExtensive phenotyping
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Jean-Sébastien HulotUniversité Paris Cité, INSERM, PARCC, Paris, France. jean-sebastien.hulot@aphp.fr.ORCID http://orcid.org/0000-0001-5463-6117
Pierre-Yves HervéFealinx, 42 route du Pont de Chêne, Francheville, France.ORCID http://orcid.org/0000-0002-5525-1750
Nicolas GirerdCHRU de Nancy, Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Nancy, France.ORCID http://orcid.org/0000-0002-3278-2057
Frédérique Chézalviel-GuilbertSanofi R&D, Gentilly, France.ORCID http://orcid.org/0000-0001-9731-4951
Philip JaniakSanofi R&D, Gentilly, France.
Pierre BoutouyrieUniversité Paris Cité, INSERM, PARCC, Paris, France.
Jean-Joseph ChristopheCASIS - CArdiac Simulation & Imaging Software, Quetigny, France.
Ariel CohenCardiology, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, ICAN 1166, Paris, France.
Thibaud DamyCardiology, AP-HP, Hôpital Henri Mondor, Créteil, France.
Liliane BerkaniClinical research unit, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
Kevin DuarteCHRU de Nancy, Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Nancy, France.
Caroline FraslonSanofi R&D, Gentilly, France.
Hüseyin FiratFiralis, Huningue, France.
Olivier HanonUMR 1144, Université Paris Cité, Department of Geriatrics, AP-HP, Hôpital Broca, Paris, France.
Richard IsnardCardiology, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
Guillaume JondeauCardiology, AP-HP, Hôpital Bichat, Paris, France.ORCID http://orcid.org/0000-0002-0101-2076
Elie MousseauxUniversité Paris Cité, INSERM, PARCC, Paris, France.ORCID http://orcid.org/0000-0002-8076-1445
Mathieu PernotPhysics for Medicine Paris, INSERM U1273, ESPCI Paris, PSL University, CNRS FRE 2031, Paris, France.ORCID http://orcid.org/0000-0001-6713-4642
Andrea Ruiz-VelascoUniversité Paris Cité, INSERM, PARCC, Paris, France.ORCID http://orcid.org/0000-0003-0660-5855
Alfonso SartoriusServier R&D, Suresnes, France.ORCID http://orcid.org/0009-0001-8498-2704
Benoit TylServier R&D, Suresnes, France.ORCID http://orcid.org/0000-0001-5297-8412
Gilles SoulatUniversité Paris Cité, INSERM, PARCC, Paris, France.
Philippe BoutinaudFealinx, 42 route du Pont de Chêne, Francheville, France.ORCID http://orcid.org/0000-0003-3662-1119
Damien LogeartUniversité Paris Cité, AP-HP, Hôpital Lariboisière, Paris, France.
PACIFIC consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure with preserved ejection fraction (HFpEF) accounts for over half of heart failure cases but remains poorly defined due to its clinical heterogeneity. In the prospective PACIFIC-Preserved cohort (NCT04189029, n = 155), we applied multimodal deep phenotyping, including high-throughput proteomics, and unsupervised machine learning to identify biologically distinct HFpEF subgroups. Multiview clustering revealed two major HFpEF phenogroups: PEF1, characterized by inflammatory signaling, TNF receptor activation, cardio-skeletal injury, and greater renal dysfunction; and PEF2, marked by endothelial stress and milder perturbations. Conventional diagnostics alone could not reliably distinguish these subgroups, but a multimodal classifier integrating clinical, imaging, and proteomic variables achieved high predictive accuracy (F1-score 0.87). External validation in the MEDIA-DHF cohort (n = 456) confirmed that PEF1 was independently associated with adverse outcomes (adjusted HR 2.27, 95% CI 1.04-4.94). These findings establish a classifier-driven, biologically informed stratification of HFpEF, providing a framework for precision medicine in heart failure.

Indexed as

Heart FailureStroke VolumeAgedCluster AnalysisClustering AlgorithmsFemaleHumansMaleMiddle AgedProspective StudiesProteomicsUnsupervised Machine Learning

Identifiers

PMID42875459
PMCPMC13669343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.